December 1, 2021 Journal article Open Access

Ayoubi, Riham; Alshafie, Walaa; Dorval, Geneviève; Durcan, Thomas M.; McPherson, Peter S.; Laflamme, Carl

MARC21 XML Export

<?xml version='1.0' encoding='UTF-8'?>
<record xmlns="http://www.loc.gov/MARC21/slim">
  <leader>00000nam##2200000uu#4500</leader>
  <datafield tag="041" ind1=" " ind2=" ">
    <subfield code="a">eng</subfield>
  </datafield>
  <datafield tag="653" ind1=" " ind2=" ">
    <subfield code="a">parkin</subfield>
  </datafield>
  <datafield tag="653" ind1=" " ind2=" ">
    <subfield code="a">Parkin</subfield>
  </datafield>
  <datafield tag="653" ind1=" " ind2=" ">
    <subfield code="a">PRKN</subfield>
  </datafield>
  <datafield tag="653" ind1=" " ind2=" ">
    <subfield code="a">prkn</subfield>
  </datafield>
  <datafield tag="653" ind1=" " ind2=" ">
    <subfield code="a">O60260</subfield>
  </datafield>
  <datafield tag="653" ind1=" " ind2=" ">
    <subfield code="a">Parkinson's</subfield>
  </datafield>
  <datafield tag="653" ind1=" " ind2=" ">
    <subfield code="a">antibody characterization</subfield>
  </datafield>
  <datafield tag="653" ind1=" " ind2=" ">
    <subfield code="a">antibody validation</subfield>
  </datafield>
  <controlfield tag="005">20211203014832.0</controlfield>
  <controlfield tag="001">5747356</controlfield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">Montreal Neurological Institute</subfield>
    <subfield code="0">(orcid)0000-0001-7999-1297</subfield>
    <subfield code="a">Alshafie, Walaa</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">Montreal Neurological Institute</subfield>
    <subfield code="a">Dorval, Geneviève</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">Montreal Neurological Institute</subfield>
    <subfield code="0">(orcid)0000-0003-3942-1956</subfield>
    <subfield code="a">Durcan, Thomas M.</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">Montreal Neurological Institute</subfield>
    <subfield code="0">(orcid)0000-0001-7806-5662</subfield>
    <subfield code="a">McPherson, Peter S.</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">Montreal Neurological Institute</subfield>
    <subfield code="0">(orcid)0000-0001-5906-025X</subfield>
    <subfield code="a">Laflamme, Carl</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2=" ">
    <subfield code="s">2373238</subfield>
    <subfield code="z">md5:aa19a1cd4eaeaf07d1a45c62f96adeb4</subfield>
    <subfield code="u">https://zenodo.org/record/5747356/files/Parkin_PRKN_YCharOS report-v4.pdf</subfield>
  </datafield>
  <datafield tag="542" ind1=" " ind2=" ">
    <subfield code="l">open</subfield>
  </datafield>
  <datafield tag="260" ind1=" " ind2=" ">
    <subfield code="c">2021-12-01</subfield>
  </datafield>
  <datafield tag="909" ind1="C" ind2="O">
    <subfield code="p">openaire</subfield>
    <subfield code="p">user-ycharos</subfield>
    <subfield code="o">oai:zenodo.org:5747356</subfield>
  </datafield>
  <datafield tag="100" ind1=" " ind2=" ">
    <subfield code="u">Montreal Neurological Institute</subfield>
    <subfield code="0">(orcid)0000-0001-6633-655X</subfield>
    <subfield code="a">Ayoubi, Riham</subfield>
  </datafield>
  <datafield tag="245" ind1=" " ind2=" ">
    <subfield code="a">Antibody Characterization Report for E3 ubiquitin-protein ligase parkin (Parkin)</subfield>
  </datafield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">user-ycharos</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
    <subfield code="u">https://creativecommons.org/licenses/by/4.0/legalcode</subfield>
    <subfield code="a">Creative Commons Attribution 4.0 International</subfield>
  </datafield>
  <datafield tag="650" ind1="1" ind2="7">
    <subfield code="a">cc-by</subfield>
    <subfield code="2">opendefinition.org</subfield>
  </datafield>
  <datafield tag="520" ind1=" " ind2=" ">
    <subfield code="a">&lt;p&gt;Head-to-head comparison of available commercial antibodies against E3 ubiquitin-protein ligase parkin (Parkin) by immunoblot (Western blot), immunoprecipitation and immunofluorescence.&lt;/p&gt;

&lt;p&gt;Work reported in this report was supported in part by the Michael J. Fox Foundation for Parkinson&amp;#39;s research.&lt;/p&gt;</subfield>
  </datafield>
  <datafield tag="773" ind1=" " ind2=" ">
    <subfield code="n">doi</subfield>
    <subfield code="i">isVersionOf</subfield>
    <subfield code="a">10.5281/zenodo.5747355</subfield>
  </datafield>
  <datafield tag="024" ind1=" " ind2=" ">
    <subfield code="a">10.5281/zenodo.5747356</subfield>
    <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">publication</subfield>
    <subfield code="b">article</subfield>
  </datafield>
</record>